Latest Upsher-Smith Laboratories Inc. Stories
Multiple Presentations Highlight Long-Term Safety, Tolerability, and Efficacy Measures, as Adjunctive Therapy for Patients with Refractory Partial-Onset Seizures SEATTLE, Dec.
Findings from Late-Breaking Abstract Demonstrate That Well-Defined Seizure Cluster Terminology is Necessary to Standardize Patient Diagnosis and Allow for Appropriate Treatment Strategies SEATTLE,
New Website Expands the Seizure Clusters Connect(TM) Community by Offering Information, Education and Resources to Support Patients and Caregivers MAPLE GROVE, Minn., Nov.
Findings Presented at 43rd Annual Meeting of the Child Neurology Society MAPLE GROVE, Minn., Oct.
Upsher-Smith Provides Funding to the Epilepsy Foundation to Commission Survey About Seizure Clusters, to be Conducted by Harris Poll® MAPLE GROVE, Minn., Sept.
An Innovative Approach That Puts Clinicians in Charge MAPLE GROVE, Minn., July 28, 2014 /PRNewswire/ -- Upsher-Smith Laboratories,
Authorized Generic Topiramate Extended-Release Capsules Available Nationwide MAPLE GROVE, Minn., July 14, 2014 /PRNewswire/ -- Upsher-Smith
Testosterone Gel (1%), the Generic Equivalent to Vogelxo(TM) (testosterone) Gel, Expected to Increase Access for Patients Who Need It MAPLE GROVE, Minn., July 2, 2014 /PRNewswire/ --
First Branded Product in CNS Portfolio Now Available MAPLE GROVE, Minn., June 30, 2014 /PRNewswire/ -- Upsher-Smith
Recently FDA Approved Qudexy(TM) XR Offers a New Treatment Option for Managing Specific Seizure Types MAPLE GROVE, Minn., June 17, 2014 /PRNewswire/ -- Results from
- To swell, as grain or wood with water.